Taken together with the evidence that blocking LPA signaling can decrease the progression of pulmonary fibrosis, it is likely that inhibitors of LPA signaling could have a significant potential in decreasing the adverse side effects of radiation therapy as well as improving the killing of residual cancer cells. The gene discussed is LPA; the disease is cancer.